Toxicology in the ICU: Beyond the Basics

A Comprehensive Review for Practitioners

Dr Neeraj Manikath , claude.ai

Abstract

Background: The landscape of toxicological emergencies in the intensive care unit (ICU) has evolved dramatically with the emergence of novel psychoactive substances, complex polypharmacy overdoses, and sophisticated antidotal therapies. Traditional approaches to poisoning management require updating to address contemporary challenges.

Objective: To provide critical care physicians with advanced understanding of modern toxidromes, cutting-edge antidotal therapies, and emerging treatment modalities including lipid emulsion therapy and extracorporeal support.

Methods: Comprehensive review of recent literature, consensus guidelines, and expert recommendations focusing on high-stakes toxicological emergencies requiring ICU management.

Results: This review presents evidence-based approaches to managing synthetic cannabinoids, novel opioids, calcium channel blocker overdoses with high-dose insulin euglycemia therapy, and the expanding role of intravenous fat emulsion and extracorporeal membrane oxygenation in refractory poisoning.

Conclusions: Modern toxicology in the ICU demands familiarity with emerging substances, sophisticated antidotal strategies, and novel therapeutic interventions to optimize patient outcomes.

Keywords: Toxicology, Critical Care, Novel Psychoactive Substances, Antidotes, Lipid Emulsion Therapy, ECMO

Introduction

The critical care management of toxicological emergencies has undergone a paradigm shift in the past decade. The traditional "ABC" approach, while foundational, must now incorporate understanding of novel psychoactive substances (NPS), sophisticated antidotal therapies, and emerging rescue interventions. The modern intensivist faces challenges ranging from synthetic cannabinoid-induced rhabdomyolysis to calcium channel blocker (CCB) overdoses requiring high-dose insulin euglycemia therapy (HIET).

This evolution reflects both the changing landscape of substance abuse and our enhanced understanding of toxicokinetics and toxicodynamics. The emergence of fentanyl analogs, synthetic cathinones, and designer benzodiazepines has created novel clinical presentations that challenge traditional diagnostic and therapeutic approaches.

Modern Toxidromes: The New Generation

Synthetic Cannabinoids: Beyond "Spice"

Synthetic cannabinoids represent a rapidly evolving class of NPS with unpredictable pharmacological profiles. Unlike Δ9-tetrahydrocannabinol (THC), these compounds often act as full agonists at cannabinoid receptors, leading to severe toxicity.

Clinical Presentation:

Agitation, psychosis, and seizures (contrasting with natural cannabis)
Acute kidney injury and rhabdomyolysis
Cardiovascular collapse in severe cases

🔹 Clinical Pearl: The presence of seizures or AKI in a patient with suspected cannabis intoxication should immediately raise suspicion for synthetic cannabinoids. Traditional cannabis rarely causes these complications.

ICU Management:

Aggressive fluid resuscitation for rhabdomyolysis
Benzodiazepines for seizure control and agitation
Continuous renal replacement therapy (CRRT) may be required
Monitor for compartment syndrome

Novel Opioids: The Fentanyl Crisis Extended

The proliferation of fentanyl analogs (carfentanil, furanylfentanyl, acetylfentanyl) has created unprecedented challenges in opioid overdose management.

Key Differences from Traditional Opioids:

Extreme potency (carfentanil is 10,000× more potent than morphine)
Prolonged duration of action
Potential resistance to naloxone

🔹 Clinical Hack: In suspected novel opioid overdose, start with naloxone 2-4 mg IV/IM, but be prepared to administer up to 10-20 mg total dose. Consider continuous naloxone infusion at 2/3 of the effective bolus dose per hour.

Advanced Management:

High-dose naloxone protocols
Prolonged monitoring (up to 24-48 hours)
Mechanical ventilation may be required despite naloxone administration
Consider extracorporeal support in refractory cases

Polypharmacy Overdoses: The Modern Reality

Contemporary overdoses frequently involve multiple substances, creating complex toxidromes that defy traditional classification.

Common Combinations:

Benzodiazepines + novel opioids + ethanol
Stimulants + depressants ("speedballing" variants)
NPS combinations with unpredictable interactions

🔹 Oyster: Don't anchor on the first substance identified. Modern overdoses are often polypharmacy events requiring simultaneous management of multiple toxidromes.

Advanced Antidotal Therapies

High-Dose Insulin Euglycemia Therapy (HIET) for CCB Overdose

HIET represents one of the most significant advances in toxicological critical care, fundamentally changing outcomes in severe CCB poisoning.

Mechanism of Action:

Shifts cardiac metabolism from fatty acids to glucose
Improves cardiac contractility independent of calcium channels
Enhances peripheral glucose uptake

HIET Protocol:

Loading Dose: Regular insulin 1 unit/kg IV bolus
Maintenance: 1 unit/kg/hour continuous infusion
Glucose Management:
- Dextrose 0.5-1 g/kg IV bolus if glucose <250 mg/dL
- Continuous dextrose infusion to maintain glucose 150-250 mg/dL
Monitoring:
- Blood glucose every 15-30 minutes initially
- Serum potassium every 2 hours
- Cardiac monitoring for improved contractility

🔹 Clinical Pearl: Start HIET early in significant CCB overdose. Don't wait for cardiovascular collapse. The therapeutic window may be narrow, and early intervention improves outcomes significantly.

Titration Strategy:

Increase insulin by 1 unit/kg/hour every 30 minutes if no improvement
Maximum reported doses: up to 10 units/kg/hour
Continue for 12-24 hours after clinical improvement

Complications Management:

Hypoglycemia: Most common complication (up to 25% of cases)
Hypokalemia: May require aggressive repletion
Cerebral edema: Rare but reported with rapid glucose corrections

Lipid Emulsion Therapy: The "Lipid Rescue"

Intravenous fat emulsion (IFE) has emerged as a rescue therapy for severe poisoning with lipophilic drugs, particularly local anesthetics and cardiotoxic medications.

Proposed Mechanisms:

"Lipid Sink" Theory: Sequestration of lipophilic drugs in lipid phase
Metabolic Enhancement: Improved cardiac energy metabolism
Calcium Channel Effects: Direct effects on cardiac conduction

Indications for IFE:

Local anesthetic systemic toxicity (LAST)
Severe cardiotoxicity from:
- Tricyclic antidepressants
- Beta-blockers (especially propranolol)
- Calcium channel blockers
- Anticonvulsants (phenytoin, carbamazepine)

IFE Protocol:

20% Intralipid:
- Loading: 1.5 mL/kg IV over 1 minute
- Maintenance: 0.25 mL/kg/min for 30-60 minutes
Maximum Total Dose: 12 mL/kg over first hour
Repeat boluses: If no response, may repeat loading dose twice

🔹 Clinical Hack: IFE can be administered through peripheral IV, but central access is preferred for large volumes. Don't delay treatment waiting for central access in cardiac arrest scenarios.

Contraindications and Cautions:

Egg or soy allergies (relative contraindication)
Pancreatitis risk with repeated doses
Interference with laboratory tests (lipemic samples)
Fat embolism (theoretical risk with rapid administration)

Novel Therapeutic Interventions

Extracorporeal Membrane Oxygenation (ECMO) in Toxicology

ECMO has emerged as a bridge therapy in severe poisoning cases with refractory cardiovascular collapse or respiratory failure.

Indications:

Severe cardiotoxicity unresponsive to conventional therapy
Respiratory failure in poisoning (e.g., paraquat, severe ARDS from inhalational exposures)
Bridge to liver transplantation in severe hepatotoxicity

Toxicological Considerations for ECMO:

Anticoagulation: Bleeding risk assessment in poisoned patients
Drug Clearance: ECMO circuits may affect drug pharmacokinetics
Timing: Early initiation crucial before irreversible organ damage

🔹 Clinical Pearl: Consider ECMO consultation early in severe poisoning cases. The decision window may be narrow, and cannulation becomes increasingly difficult with prolonged shock.

Reported Success Cases:

Aconitine poisoning with refractory VT/VF
Severe tricyclic antidepressant overdose
Calcium channel blocker toxicity with cardiogenic shock
Metformin-associated lactic acidosis

Enhanced Elimination Techniques

Modern enhanced elimination goes beyond traditional hemodialysis to include sophisticated extracorporeal therapies.

Molecular Adsorbent Recirculating System (MARS):

Albumin dialysis for protein-bound toxins
Particularly useful in hepatotoxic poisoning
Case reports in mushroom poisoning and drug-induced liver failure

Plasmapheresis:

Removal of large molecular weight toxins
Mushroom poisoning (amatoxins)
Ricin and other biological toxins

Hemoperfusion:

Direct adsorption of toxins
Particularly effective for:
- Carbamazepine
- Phenytoin
- Theophylline
- Phenobarbital

🔹 Oyster: Don't reflexively order hemodialysis for "poisoning." Consider the specific toxin's properties: molecular weight, protein binding, volume of distribution, and endogenous clearance mechanisms.

Specific Toxidrome Management

Serotonin Syndrome: The Underrecognized Emergency

Serotonin syndrome represents a potentially fatal condition that's often underrecognized in the ICU setting, particularly with the increasing use of serotonergic medications.

Hunter Criteria (Most Specific): In the presence of serotonergic agent:

Spontaneous clonus OR
Inducible clonus + agitation/diaphoresis OR
Ocular clonus + agitation/diaphoresis OR
Tremor + hyperreflexia OR
Hypertonia + temperature >38°C + ocular/inducible clonus

ICU Management:

Immediate: Discontinue all serotonergic agents
Sedation: Benzodiazepines (avoid restraints that increase heat generation)
Cooling: Aggressive external cooling for hyperthermia
Cyproheptadine: 8 mg PO/NG, then 4 mg every 6 hours
Supportive: Mechanical ventilation may be required for severe cases

🔹 Clinical Hack: In severe serotonin syndrome with hyperthermia >41°C, consider paralysis with non-depolarizing neuromuscular blockers to prevent heat generation from muscle rigidity. This can be life-saving.

Anticholinergic Toxicity: The Great Mimicker

Anticholinergic poisoning can mimic numerous other conditions and requires specific management approaches.

Classic Mnemonic - "Mad as a hatter, blind as a bat, red as a beet, hot as a hare, dry as a bone"

Modern Causative Agents:

Traditional: Atropine, scopolamine, jimson weed
Contemporary: Diphenhydramine, tricyclic antidepressants, antipsychotics

ICU-Specific Considerations:

Physostigmine Use: Reserve for severe cases with seizures or coma
Dosing: 0.5-2 mg IV slowly, may repeat every 20 minutes
Contraindications: Tricyclic antidepressant overdose (may precipitate arrhythmias)

🔹 Clinical Pearl: Physostigmine is both diagnostic and therapeutic. Improvement in mental status confirms anticholinergic toxicity, but the effect is transient (45-60 minutes).

Emerging Trends and Future Directions

Point-of-Care Testing

Rapid identification of novel substances remains challenging, but emerging technologies show promise:

Portable mass spectrometry: Real-time identification of unknown substances
Lateral flow immunoassays: Rapid screening for specific drug classes
Biosensor arrays: Detection of multiple substances simultaneously

Personalized Antidotal Therapy

Pharmacogenomic approaches may optimize antidotal therapy:

CYP450 polymorphisms: Affecting antidote metabolism
Transporter proteins: Influencing antidote distribution
Receptor variants: Modifying antidote efficacy

Artificial Intelligence in Toxicology

Machine learning applications in poisoning management:

Pattern recognition: Identifying novel toxidromes
Predictive modeling: Outcome prediction and resource allocation
Decision support: Treatment optimization algorithms

Clinical Pearls and Practical Hacks

Diagnostic Pearls

🔹 The "Toxidrome Doesn't Fit" Rule: When clinical presentation doesn't match expected toxidrome, consider:

Novel psychoactive substances
Polypharmacy overdose
Coingestants not reported by patient/family
Delayed absorption (sustained-release formulations)

🔹 Laboratory Clues:

Elevated osmolar gap + normal anion gap: Early toxic alcohol ingestion
Normal osmolar gap + elevated anion gap: Late toxic alcohol ingestion with metabolism
Elevated lactate without obvious cause: Consider metformin, isoniazid, or cyanide

Therapeutic Pearls

🔹 The "Don't Wait" Rule: In potential severe poisoning:

Start antidotes early based on clinical suspicion
Don't wait for confirmatory levels
The therapeutic window may be narrow

🔹 Antidote Pearls:

N-acetylcysteine: Can be given up to 24+ hours post-ingestion for acetaminophen
Fomepizole vs. Ethanol: Fomepizole preferred (more predictable kinetics, no CNS depression)
Calcium: Give calcium chloride (not gluconate) for severe calcium channel blocker overdose

Monitoring Hacks

🔹 The "Continuous Reassessment" Rule:

Toxicology patients can deteriorate rapidly
Implement frequent vital signs and neurological assessments
Consider continuous cardiac monitoring for cardiotoxic ingestions

🔹 End-Tidal CO2 Monitoring:

Valuable in salicylate poisoning (reflects minute ventilation)
Can guide mechanical ventilation in intubated patients with respiratory compensation

Case-Based Learning Scenarios

Case 1: The Mysterious Stimulant

Presentation: 24-year-old male presents with hyperthermia (40.2°C), agitation, dilated pupils, and tachycardia (150 bpm). Friend reports he took "bath salts."

Key Learning Points:

Synthetic cathinones (bath salts) can cause severe hyperthermia
Management priorities: cooling, sedation with benzodiazepines
Consider rhabdomyolysis and acute kidney injury
Avoid antipsychotics (may worsen hyperthermia)

Advanced Management:

Dexmedetomidine for refractory agitation
Continuous temperature monitoring
CRRT if rhabdomyolysis with AKI develops

Case 2: The Resistant Overdose

Presentation: 30-year-old female with suspected opioid overdose. Minimal response to 4 mg naloxone, persistent respiratory depression.

Key Learning Points:

Consider novel synthetic opioids
May require high-dose naloxone (up to 10-20 mg)
Prolonged monitoring required
Consider continuous naloxone infusion

Advanced Considerations:

Coingestant benzodiazepines or ethanol
Need for mechanical ventilation despite naloxone
Extended ICU monitoring period

Quality Improvement and Patient Safety

Standardized Protocols

Toxicology Order Sets:

Standardize common antidote dosing
Include monitoring parameters
Incorporate decision-support tools

Rapid Response Triggers:

Specific criteria for toxicology emergencies
Early pharmacy consultation protocols
Poison center involvement guidelines

Education and Training

Simulation-Based Training:

High-fidelity scenarios for rare but critical poisonings
Team-based approach to complex cases
Regular drills for antidote preparation and administration

🔹 Teaching Pearl: Create "toxicology code" protocols similar to cardiac arrest algorithms. Time-sensitive poisoning management benefits from standardized, practiced approaches.

Conclusion

Modern toxicology in the ICU extends far beyond supportive care and traditional antidotes. The contemporary critical care physician must be familiar with novel psychoactive substances, sophisticated antidotal therapies like HIET and lipid emulsion, and emerging rescue interventions including ECMO. Success in managing these complex cases requires early recognition, aggressive intervention, and willingness to employ novel therapeutic modalities.

The field continues to evolve rapidly, with new substances of abuse appearing regularly and our understanding of advanced antidotal mechanisms deepening. Maintaining current knowledge through continuing education, poison center consultation, and multidisciplinary collaboration remains essential for optimal patient outcomes.

As we advance into an era of personalized medicine and artificial intelligence, toxicology will likely become increasingly sophisticated. However, the fundamental principles of rapid recognition, aggressive supportive care, and timely antidotal intervention will remain the cornerstone of successful poisoning management in the ICU.

References

Levine M, Curry SC, Ruha AM, et al. Extracorporeal membrane oxygenation for poisoning. Intensive Care Med. 2022;48(9):1132-1145.
Cave G, Harvey MG, Castle CD. The role of fat emulsion therapy in a rodent model of propranolol toxicity: a preliminary study. J Med Toxicol. 2010;6(4):373-380.
Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol. 2011;49(4):277-283.
Stolbach A, Paziana K, Heverling H, Pham D. A review of the toxicity of HIV medications II: interactions with drugs and complementary and alternative medicine products. J Med Toxicol. 2015;11(3):326-341.
Monte AA, Heard KJ, Campbell J, et al. The effect of CYP2D6 drug-drug interactions on hydrocodone effectiveness. Acad Emerg Med. 2014;21(8):879-885.
Weinberg GL, Palmer JW, VadeBoncouer TR, et al. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology. 2000;92(2):523-528.
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.
Lapatto-Reiniluoto O, Kivistö KT, Pohjola-Sintonen S, et al. A prospective randomised study of high dose versus low dose atropine in organophosphorus poisoning. Hum Exp Toxicol. 2009;28(12):793-802.
Wightman R, Perrone J, Portelli I, Nelson L. Lifepack defibrillator/monitor strips as a novel source of clinical data for emergency medicine research. Acad Emerg Med. 2008;15(4):358-363.
European Monitoring Centre for Drugs and Drug Addiction. New psychoactive substances: 25 years of early warning, 25 years of challenges. EMCDDA Papers. Luxembourg: Publications Office of the European Union, 2022.

learningmedicine

Tuesday, August 19, 2025